Mid-term results show no significant difference in postoperative clinical outcome, pain and range of motion between a well-established total knee arthroplasty design and its successor: a prospective, randomized, controlled trial - Takeaways - MDSpire

Mid-term results show no significant difference in postoperative clinical outcome, pain and range of motion between a well-established total knee arthroplasty design and its successor: a prospective, randomized, controlled trial

  • By

  • Georg Hauer

  • Nina Hörlesberger

  • Sebastian Klim

  • Gerwin A. Bernhardt

  • Lukas Leitner

  • Mathias Glehr

  • Andreas Leithner

  • Patrick Sadoghi

  • April 24, 2020

  • 0 min

Share

  • 1

    The study compared the clinical outcomes of the PFC Sigma and Attune TKA designs in patients undergoing total knee arthroplasty.

  • 2

    No significant differences were found in postoperative pain, range of motion, or clinical scores between the two TKA designs after two years.

  • 3

    The study included 200 patients, with 80 in the Attune group and 78 in the PFC group assessed at the two-year follow-up.

  • 4

    Both TKA designs were evaluated using standardized clinical outcome measures, including WOMAC and VAS scores.

  • 5

    The research adhered to ethical standards, with informed consent obtained and approval from the ethics committee of the Medical University of Graz.

Original Source(s)

Mid-term results show no significant difference in postoperative clinical outcome, pain and range of motion between a well-established total knee arthroplasty design and its successor: a prospective, randomized, controlled trial

  • by Georg Hauer, Nina Hörlesberger, Sebastian Klim, Gerwin A. Bernhardt, Lukas Leitner, Mathias Glehr, Andreas Leithner, Patrick Sadoghi

  • April 24, 2020

Related Content

Efficacy and safety of different curcumin formulations in osteoarthritis: an umbrella review of systematic reviews

Can Insoles Detect Disease Early?

AI-powered wearable identifies gait changes linked to neurological and musculoskeletal conditions

  • April 6, 2026

  • 3 min
Impact of Sulfate-Arsenical-Ferruginous Water on Apoptosis, Oxidative Stress, and Gene Expression of Inflammatory Mediators and MicroRNA in Human Osteoarthritic Chondrocytes Stimulated by IL-1β